Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EDGE Consortium: Preoperative Antibiotics for PCNL (Moderate Risk)
NCT02829060Completed
- Sponsor
- University of California, San Diego
- Start
- Jan 2016
- Primary completion
- Jan 2025
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, open-label trial of nitrofurantoin in sepsis and urinary tract infection (UTI) (6 arms), sponsored by University of California, San Diego. Primary endpoint: Postoperative Sepsis at 30 days. Started Jan 2016; status: completed.
02
Drugs
nitrofurantoin
03
Conditions
sepsisurinary tract infection (UTI)
Beyond the preview
Go deeper on NCT02829060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02829060.